122 related articles for article (PubMed ID: 4397539)
1. Hemodynamic effects of alprenolol (H56-28).
Proctor JD; Allen FJ; Wasserman AJ
Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):363-77. PubMed ID: 4397539
[No Abstract] [Full Text] [Related]
2. Effect of adrenergic beta receptor blocking agents on cardiac output.
Madan BR; Gupta RS
Indian Heart J; 1970 Apr; 22(2):70-2. PubMed ID: 4400289
[No Abstract] [Full Text] [Related]
3. [Coronary flow and and cardiac output of waking dogs during physical exertion under beta-receptor blockade].
Kucharczyk M; Holtz J; Stoian D; Bassenge E
Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):384-5. PubMed ID: 4397504
[No Abstract] [Full Text] [Related]
4. Circulatory effects of oxprenolol, a new beta-adrenergic blocking agent.
Reale A; Motolese M; Imhof P
Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):288-93. PubMed ID: 4394124
[No Abstract] [Full Text] [Related]
5. Cardiovascular effects of equi-antiarrhythmic doses of alprenolol (a beta-adrenergic receptor antagonist) diphenylhydantoin and procainamide.
Proctor JD; Allen FJ; Wasserman AJ
Arch Int Pharmacodyn Ther; 1971 Apr; 190(2):354-67. PubMed ID: 4396926
[No Abstract] [Full Text] [Related]
6. [Effects of ICI 50,172 on cardio-respiratory parameters in dogs].
Tavares P; Viana AR; Ximenes-Neto M; Martinelli JG
Rev Bras Anestesiol; 1971; 21(4):596-601. PubMed ID: 4401689
[No Abstract] [Full Text] [Related]
7. Effects of oxprenolol on coronary circulation and cardiac metabolism.
Drimal J; Aviado DM
J Pharmacol Exp Ther; 1971 Feb; 176(2):312-9. PubMed ID: 4398185
[No Abstract] [Full Text] [Related]
8. Some haemodynamic effects of LB 46 (Visken).
Smyth AJ; Watson O; Peel JS; Turner AS
N Z Med J; 1970 Oct; 72(461):246-7. PubMed ID: 4395124
[No Abstract] [Full Text] [Related]
9. Pharmacological aspects of oxprenolol.
Brunner H; Hedwall PR; Maier R; Meier M
Postgrad Med J; 1970 Nov; ():Suppl:5-14. PubMed ID: 4395460
[No Abstract] [Full Text] [Related]
10. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
Suzuki K; Kubota M; Odashiro M; Yasuda K; Goto Y
Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
[No Abstract] [Full Text] [Related]
11. [Hemodynamic effects of a new inhibitor of adrenergic beta receptors (LB 46)].
Lejwi G; Fabiato A; Gut JP; Gourgon R
Arch Mal Coeur Vaiss; 1971 Nov; 64(11):1654-68. PubMed ID: 4402388
[No Abstract] [Full Text] [Related]
12. Sympathetic control of coronary and systemic hemodynamics in emotional stress in the conscious dog.
Bergamaschi M; Shanks RG; Mandelli V
Recent Adv Stud Cardiac Struct Metab; 1973; 3():399-407. PubMed ID: 4157080
[No Abstract] [Full Text] [Related]
13. [Rapid screening of beta adrenergic receptor blockaders in humans].
Fuccella LM
Boll Chim Farm; 1972 Jun; 111(6):366-75. PubMed ID: 4403256
[No Abstract] [Full Text] [Related]
14. An experimental study of the beta-receptor blocking agents on the cardiac performance in dogs.
Singh N; Srivastava RK; Kulshrestha VK; Sinha JN; Kohli RP; Bhargava KP
Jpn J Pharmacol; 1970 Dec; 20(4):467-72. PubMed ID: 4395619
[No Abstract] [Full Text] [Related]
15. The effect of bea-adrenergic blockade on the cardiopulmonary response to ketamine.
Traber DL; Wilson RD; Priano LL
Anesth Analg; 1970; 49(4):604-13. PubMed ID: 4397093
[No Abstract] [Full Text] [Related]
16. Hemodynamic effects of practolol at rest and during exercise.
Leon DF; Thompson ME; Shaver JA; McDonald RH
Circulation; 1972 Jan; 45(1):46-54. PubMed ID: 4399771
[No Abstract] [Full Text] [Related]
17. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
Baum T; Rowles G; Shropshire AT; Gluckman MI
J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
[No Abstract] [Full Text] [Related]
18. Effects of beta-adrenergic blockade on the hemodynamic response to carotid sinus reflexes.
Lacroix E; Demeester G; Leusen I
Arch Int Pharmacodyn Ther; 1968 Oct; 175(2):447-63. PubMed ID: 5702960
[No Abstract] [Full Text] [Related]
19. Hemodynamic effects of nethalide.
Vogin EE; Rice AJ
Arch Int Pharmacodyn Ther; 1965 Jun; 155(2):317-25. PubMed ID: 4953960
[No Abstract] [Full Text] [Related]
20. [Cardiovascular action of a new beta receptor blocking agent: KO 592].
Brugger AJ
Rev Esp Fisiol; 1967 Dec; 23(4):215-20. PubMed ID: 4391109
[No Abstract] [Full Text] [Related]
[Next] [New Search]
